Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Evolution of information-driven HIV/AIDS policies in China.

Sun X, Lu F, Wu Z, Poundstone K, Zeng G, Xu P, Zhang D, Liu K, Liau A.

Int J Epidemiol. 2010 Dec;39 Suppl 2:ii4-13. doi: 10.1093/ije/dyq217. Review.

2.

Evolution of China's response to HIV/AIDS.

Wu Z, Sullivan SG, Wang Y, Rotheram-Borus MJ, Detels R.

Lancet. 2007 Feb 24;369(9562):679-90. Review.

PMID:
17321313
3.

HIV/AIDS epidemiology and prevention in China.

Sheng L, Cao WK.

Chin Med J (Engl). 2008 Jul 5;121(13):1230-6. Review.

PMID:
18710645
4.

Drug use and HIV/AIDS in China.

Liu Z, Lian Z, Zhao C.

Drug Alcohol Rev. 2006 Mar;25(2):173-5. Review.

PMID:
16627308
5.

The HIV/AIDS epidemic in China: history, current strategies and future challenges.

Wu Z, Rou K, Cui H.

AIDS Educ Prev. 2004 Jun;16(3 Suppl A):7-17. Review.

PMID:
15262561
6.

Overview of the HIV/AIDS epidemic, scientific research and government responses in China.

Wang L.

AIDS. 2007 Dec;21 Suppl 8:S3-7. doi: 10.1097/01.aids.0000304690.24390.c2. Review.

PMID:
18172388
7.

Rapid scale up of harm reduction in China.

Sullivan SG, Wu Z.

Int J Drug Policy. 2007 Mar;18(2):118-28. Epub 2007 Feb 14. Review.

PMID:
17689354
8.

Current progress of China's free ART program.

Zhang FJ, Pan J, Yu L, Wen Y, Zhao Y.

Cell Res. 2005 Nov-Dec;15(11-12):877-82. Review.

9.

HIV/AIDS policy and policy evolution in China.

Xue B.

Int J STD AIDS. 2005 Jul;16(7):459-64. Review.

PMID:
16004623
10.

The HIV/AIDS epidemic in Nigeria: progress, problems and prospects.

Aliyu MH, Varkey P, Salihu HM, Iliyasu Z, Abubakar IS.

Afr J Med Med Sci. 2010 Sep;39(3):233-9. Review.

PMID:
21416794
11.

Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.

Birkhead GS, Klein SJ, Candelas AR, O'Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA.

Int J Drug Policy. 2007 Oct;18(5):417-25. Epub 2007 Feb 20. Review.

PMID:
17854731
12.

What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries.

Degenhardt L, Mathers BM, Wirtz AL, Wolfe D, Kamarulzaman A, Carrieri MP, Strathdee SA, Malinowska-Sempruch K, Kazatchkine M, Beyrer C.

Int J Drug Policy. 2014 Jan;25(1):53-60. doi: 10.1016/j.drugpo.2013.08.004. Epub 2013 Sep 4. Review.

PMID:
24113623
13.
14.

'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam.

Hammett TM, Wu Z, Duc TT, Stephens D, Sullivan S, Liu W, Chen Y, Ngu D, Des Jarlais DC.

Addiction. 2008 Jan;103(1):137-45. Epub 2007 Nov 20. Review.

PMID:
18028519
15.

The development of HIV/AIDS surveillance in China.

Sun X, Wang N, Li D, Zheng X, Qu S, Wang L, Lu F, Poundstone K, Wang L.

AIDS. 2007 Dec;21 Suppl 8:S33-8. doi: 10.1097/01.aids.0000304694.54884.06. Review.

PMID:
18172389
16.

Injection drug use and HIV/AIDS transmission in China.

Chu TX, Levy JA.

Cell Res. 2005 Nov-Dec;15(11-12):865-9. Review.

17.

Harm reduction theories and strategies for control of human immunodeficiency virus: a review of the literature.

Hilton BA, Thompson R, Moore-Dempsey L, Janzen RG.

J Adv Nurs. 2001 Feb;33(3):357-70. Review.

PMID:
11251723
18.

National and state policies influencing the care of children affected by AIDS.

Salisbury KM.

Child Adolesc Psychiatr Clin N Am. 2000 Apr;9(2):425-49. Review.

PMID:
10768076
19.

Link to slower access to care: what is the stigma?: an Indian perspective.

Kandwal R, Bahl T.

Curr HIV/AIDS Rep. 2011 Dec;8(4):235-40. doi: 10.1007/s11904-011-0096-2. Review.

PMID:
21898073
20.

Care of HIV-infected patients in China.

Cao YZ, Lu HZ.

Cell Res. 2005 Nov-Dec;15(11-12):883-90. Review.

Supplemental Content

Support Center